Results per Page:
HIV’s secret sweet tooth: T cell glycosylation determines variant entry
From the Overbaugh Lab, Human Biology and Public Health Sciences Divisions
Bottleneck breakthrough
Fred Hutch researchers discover why some HIV-1 variants are more transmissible than others, which could generate new approaches to stop the virus that causes AIDS at cell entry
Hopes and predictions for 2022
Hutch researchers look ahead to an increase in cancer screening, improved vaccines and greater trust in science
World AIDS Day 2021: Let's give the gifts of hope and focus to HIV research
HIV scientific infrastructure paved the way for the world’s COVID-19 response. Now, it’s time to return the favor.
Experimental Phase 2b HIV Vaccine Regimen Provides Insufficient Protection in Preventing HIV
No safety signals of concern for study participants
New bacterium named in honor of Fred Hutch
First organism named after research center linked to bacterial vaginosis, higher HIV risk
Antigen boost helps CAR-T cells control viral load in SHIV infected animals
From the Kiem Group, Clinical Research Division
Injectable HIV drug prevents infections
Early data shows fewer infections than with daily pill; trial halted
Dr. Hans-Peter Kiem elected vice president of American Society of Gene & Cell Therapy
After serving 1 year as vice president, Kiem will serve as president-elect and president of the society
Superinfection provides insights into HIV-1 reservoir dynamics
From the Overbaugh/Lehman lab, Human Biology Division.
Fred Hutch honors local HIV cure activists, volunteers
Seattle's defeatHIV Community Advisory Board receives impact award
Scientists gather in Seattle to share strategies for an HIV cure
Workshop focuses on ways to lower cost, broaden reach of gene therapy